Trialbee Partners with Clinerion to Accelerate Patient Recruitment for Clinical Trials

▴ Trialbee Partners with Clinerion to Accelerate Patient Recruitment for Clinical Trials
Expanded access to global real-world data to accelerate patient recruitment for Clinical Trials

Trialbee, a leading global technology provider for patient matching and engagement in clinical trials, announced a partnership with Clinerion, a worldwide leader in medical data informatics with a global research network comprised of 30.2 million patients online across 69 healthcare organizations in 15 countries. This partnership will accelerate time to market by shortening patient recruitment and enrollment timelines and will reduce costs associated with patient recruitment and loss-to-follow-up.

“This partnership significantly broadens our global reach and allows us to expand our data set for predictable intelligence-based patient recruitment and retention to support traditional and decentralized trials,” said Lollo Eriksson, CEO of Trialbee. “This is a great opportunity for both organizations to make trials simpler for investigators and to deliver on our commitment of expediting clinical research by optimizing the use of real-world data.”

More than eighty percent of trials are delayed and approximately thirty percent of sites never enroll patients because of limited access to patients who match the study criteria. The combination of Clinerion’s expertise in leveraging real-time, real-patient, and real-world electronic health record (EHR) data for clinical research combined with Trialbee’s unique multiple step qualification process, which includes online qualification and nurse practitioner interviews to ensure high-quality patient matches prior to obtaining consent and enrollment, will significantly improve and streamline this process. The Trialbee platform provides full transparency of the status of the referred patient flow throughout the entire clinical trial and continuously offers sites and sponsors full insight into the effectiveness of recruitment strategies.

“Patients are at the center of everything Clinerion does, and this partnership will ensure better outcomes for patients,” says Ian Rentsch, CEO of Clinerion. “Together, we will be able to match more of the right patients to the leading-edge trials that can bring them the care they need. And, ultimately, our improvement of the efficiency of recruitment for clinical trials will accelerate the introduction of new medicines and interventions.”

About Trialbee

Trialbee is a world leading technology provider in patient matching and engagement, empowering patients to participate in clinical trials as a care option. Founded in 2010, Trialbee has continuously innovated patient-centric technology solutions for global clinical trials. Trialbee – Dedicated to patients; driven by science; and powered by data.

Tags : #Trialbee #Clinerion #AccesstoRealWorldGlobalData #LatestCovidNewsUpdateAug28 #LatestPharmaNewsUpdateAug28 #LatestPharmaMergerNewsAug28

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024
The Future of Healthcare: 10 ways Telehealth is Improving Patient Outcomes and Reducing CostsMay 03, 2024
Understanding the Effects of a Keto Diet on Your Body: A One-Month JourneyMay 03, 2024
High Blood Pressure in Youth: A Precursor to Severe Heart ConditionsMay 03, 2024
High Blood Pressure in Youth: A Precursor to Severe Heart ConditionsMay 03, 2024
Microplastics in Human Brains: Understanding the Emerging Health ConcernMay 03, 2024
Federal Bank Wraps Up FY 24 With 24% Rise in Profit, highest NII, Maintains Robust Asset QualityMay 02, 2024
Two Aveksha Day Care Centers for Construction Workers’ Children opened on the occasion of Labour Day May 02, 2024
AbbVie India and Sightsavers India Collaborate to Raise Awareness on GlaucomaMay 02, 2024
Whither social justice and decent work for women?May 02, 2024
Hyderabad's senior anesthesiologist at the L V Prasad Eye Institute, Dr Raja Narsing Rao elected as President of the World Congress of Ophthalmic AnaesthesiaMay 02, 2024
Navigating Legal Waters: Covishield's Side Effects Prompt Legal Battle from Parents May 02, 2024
Mumps Resurgence in India: Understanding the Recent Outbreak and Prevention StrategiesMay 02, 2024
Genomic Insights Unveiled: Illumina and Garvan Institute Collaborate to Map Disease FingerprintsMay 02, 2024
2 Months Post-Surgery, Patient Returns To Normal Life After Wide-Glossectomy With Microvascular ReconstructionApril 30, 2024
Wolfpack Labs - Aakash Anand Launches New Venture Studio Fostering Growth and Collaboration Among Early-Stage Entrepreneurs; Aims to become the biggest seeder of GTM-ready startups for leading VCsApril 30, 2024